Today

Smith Micro Software registered 18.2 million shares for resale, representing a substantial overhang from convertible notes and warrants.

Cycurion registered 25.9 million shares for resale, including ELOC and convertible stock, representing a 225.6% overhang against current outstanding shares.

Mondee Holdings registered a substantial resale of 75.5 million shares, representing 92.8% of outstanding Class A Common Stock, creating significant potential overhang.

Artelo Biosciences' S-1/A details a mixed offering of 1.64 million shares or pre-funded warrants, indicating substantial potential dilution.

Linkers Industries filed an F-1 for Units with zero-exercise Series B Warrants, posing significant dilution risk to Class A Ordinary Shareholders.

Can-Fite BioPharma registered a mixed offering of ADSs and warrants, with significant potential dilution and variable terms.

Akari Therapeutics registered 5.99 million ADSs for resale by selling shareholders, representing a 523.9% potential overhang, with the company receiving no proceeds from the resale itself.

Veea Inc. filed a universal shelf registration for up to $75.0 million, representing 873.9% of its current market cap. This creates significant future dilution potential, though no active sale is launched yet.

Xilio Therapeutics updated its ATM program to $14.5 million, representing 25.2% of its public float, with sales through Leerink Partners under a larger $250 million shelf registration.

Rubico Inc. registers a mixed offering of up to 3.34 million Units, various warrants, and 50 million equity line resale shares, posing significant potential dilution.

Akari Therapeutics registered a mixed offering of ADSs and warrants, with the initial offering alone representing over 100% of current ADSs outstanding.

Sow Good Inc. launched an ATM offering to sell up to $100 million in common stock, representing 87.5% of its market value, through Craft Capital Management LLC.

Hitek Global is offering up to 19.15M Class A Ordinary Shares, including 15.15M shares from zero-price exercise warrants, in a direct offering, leading to over 2,200% potential dilution.

AMC Entertainment is selling 95.25 million common shares at $2.10 per share in a registered direct offering, resulting in approximately $189 million in net proceeds and significant dilution for existing shareholders.

Kiora Pharmaceuticals registers 11.8M shares for resale, including 10.8M warrant-underlying shares, representing a 266% potential overhang against current shares outstanding.

Empery Digital is raising $25.0M through a direct offering of common stock and warrants, potentially diluting existing shareholders by 32.6%.

Aptevo Therapeutics filed an S-1/A to register up to 12.99 million shares and pre-funded warrants, along with 376.62 million underlying shares from warrants, and 46.12 million shares from Series C and D warrants in a concurrent private placement, representing substantial potential dilution.

Healthcare Triangle registers 1.48 billion shares for resale by selling stockholders, including 1.08 billion shares from Series B warrants with a zero exercise price option, indicating significant potential dilution.

Auddia registered a mixed offering of common stock, pre-funded warrants, and common warrants, potentially leading to significant dilution.

Innovation Beverage Group's F-1 filing for units with shares and warrants could significantly dilute existing shareholders due to the large number of potential new shares, warrant exercise, and the best-efforts nature of the offering.